Search Results

Results 151 - 160 of 789 for stem cells. (4.09 seconds)
  • ‘Drugs’ from gut bugs

    Stanford researchers found that manipulating the gut microbe Clostridium sporogenes changed levels of molecules in the bloodstreams of mice and, in turn, affected their health.

  • Alvarez receives 2017 Marsh O’Neill Award

    Mike Alvarez, the animal care supervisor in the Veterinary Service Center, received the 2017 Marsh O’Neill award. The award is one of the few opportunities for faculty to acknowledge publicly the support of outstanding staff members who support their research activity.

  • Scientists awarded grant for autism study

    The grant will help Stanford investigators find out if variants in many different autism-linked genes trigger the condition by affecting molecular pathways and cellular processes.

  • RNA labeling reveals stem cell secrets

    The Stanford research suggests that any conclusions about stem cell function based on studies of stem cells in lab dishes may now need to be reconsidered in light of the fact that the cells’ biology changes during isolation.

  • Researchers discover lung stem cell in mice

    Stanford scientists have found a cell that creates the two different compartments in the mouse lung. They hope their discovery could lead to better therapies for people with lung disease.

  • Faculty appointed to endowed professorships

    Six faculty members at the School of Medicine have been appointed to endowed professorships, and one has been appointed to an endowed directorship.

  • Five researchers receive NIH funding

    Five Stanford scientists are among the 86 nationwide who have received awards from the National Institutes of Health’s High-Risk, High-Reward program.

  • Speeding up research into rare disease

    A Stanford “lending library” of biological samples and genomic information could accelerate diagnostic and therapeutic research for NGLY1 deficiency and related conditions.

  • Sickle cell anemia treatment nears trial

    The grant will be used fund work that needs to be done before asking the Food and Drug Administration to sign off on the potential treatment as an investigational new drug.

  • Brain tumor growth stopped

    High-grade gliomas, a group of aggressive brain tumors, cease growing in mice if a signaling molecule called neuroligin-3 is absent or its activity is blocked with drugs, a Stanford team has shown.